|
|
Post by biotec on Dec 18, 2013 16:55:29 GMT -5
I saw this on ymb this morning. Im not a member to that forum. But saw a great conversation going on. Why all the talk about the 74 day letter? The last 2 trys I never heard of the 74 day letter. Is this new? And the last two times if there was a 74 day letter the stock price did nothing. I dont think it will do much this time also. So my question is why all the hype this time? I dont consider this a upcoming major event. I hope Im wrong. And I looked back a couple yrs and no partnership ever was due to a good/bad 74 day letter. (sorry for anyone that already read the YMB) Im hoping some here are not on that furom. Thanks
jmo
bio
|
|
|
|
Post by rak5555 on Dec 18, 2013 20:16:47 GMT -5
bio - IMO the only reason many of us are focused on the 74 day letter is because Matt Pfeffer (MNKD CFO) referenced the letter in recent CC as a possible gatekeeper to partnership negotiations. Also IMO, this may be a tipoff that MNKD is seeking such a substantial financial commitment from prospective partners that the partners find it necessary to wait for the letter to assist in determining whether MNKD is truly on clear path to approval.
|
|
|
|
Post by rak5555 on Dec 27, 2013 10:08:47 GMT -5
Today (or at least this weekend) is the technical due date for the letter. I can tell from YMB that folks are pestering Matt to issue PR whether it is positive (in line w/ management expectations) or negative. You may recall Hakan said they may not issue PR if letter is in line w/ expectations. As best I can recall, mnkd did not issue PR concerning 74 day letter with prior filings; however, I feel as though mnkd changed the situation when they brought attention to the letter in recent CC where they stated letter may be needed to complete partner negotiations. They should issue a PR within a week.
|
|
|
|
Post by brentie on Dec 27, 2013 10:42:18 GMT -5
Rak,I would hope that you are right but Hakan did say that if there wasn't any surprises they would probably discuss it at a conference.JP Morgan's conference is in a couple of weeks. They may wait until then. globalbiodefense.com/events/jp-morgan-32nd-annual-healthcare-conference/ VGraig Suvannavejh - MLV & Co Okay, great. And just as it relates to the 74-day letter, is that something you think you would announce in terms of a press release, in terms of the contents of what might be in that letter to the public in terms of our press release? Hakan Edstrom - President, Chief Operating Officer, Director Well as I said, normally the expectation would be that after confirmation of what's been forthcoming already from the FDA, if there is certain material event there, if there, for instance would be a request for a advisory board meeting, we would certainly make that information public because that's material information. So I would say, if the content is what we expect to be not necessarily a press release, we might certainly mention in, maybe in an investor conference or anything like that, but again if there is material information, we would certainly would share it with the shareholders. |
|
|
|
Post by biotec on Dec 27, 2013 11:36:55 GMT -5
So pretty much no news is good news.And if theres a PR it might be that the 74 day letter requires a advisory board meeting, or other not so good news. So it looks like we might have to wait until the JP Morgan conference for any news. 17 more days.
bio
|
|
|
|
Post by liane on Dec 27, 2013 12:20:50 GMT -5
No news is indeed good news. Anything adverse, or a potential Adcom would have to be disclosed. Now, we don't necessarily have to wait until JPM - partnership could be announced at any time.
|
|
/production/original_573352236.gif)
